• bitcoinBitcoin(BTC)$81,305.001.86%
  • Midas Fasanara Global EuroMidas Fasanara Global Euro(MGLOEURO)$111,813.00-0.36%
  • ethereumEthereum(ETH)$2,361.262.08%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$758.812.71%
  • rippleXRP(XRP)$1.331.84%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$102.722.73%
  • tronTRON(TRX)$0.3318191.26%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.00%
  • zcashZcash(ZEC)$1,303.904.23%
  • HyperliquidHyperliquid(HYPE)$81.464.77%
  • dogecoinDogecoin(DOGE)$0.0800973.75%
  • moneroMonero(XMR)$606.072.11%
  • USDSUSDS(USDS)$1.000.02%
  • whitebitWhiteBIT Coin(WBT)$78.081.82%
  • chainlinkChainlink(LINK)$11.763.59%
  • leo-tokenLEO Token(LEO)$9.434.35%
  • cardanoCardano(ADA)$0.2066461.50%
  • nearNEAR Protocol(NEAR)$4.663.94%
  • stellarStellar(XLM)$0.1714842.03%
  • bitcoin-cashBitcoin Cash(BCH)$297.906.28%
  • RainRain(RAIN)$0.007022-0.71%
  • Ethena USDeEthena USDe(USDE)$1.000.04%
  • daiDai(DAI)$1.00-0.01%
  • litecoinLitecoin(LTC)$57.612.38%
  • uniswapUniswap(UNI)$7.141.59%
  • CantonCanton(CC)$0.1014524.73%
  • avalanche-2Avalanche(AVAX)$8.992.63%
  • USD1USD1(USD1)$1.000.03%
  • suiSui(SUI)$0.942.97%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.241.80%
  • hedera-hashgraphHedera(HBAR)$0.0762060.47%
  • tether-goldTether Gold(XAUT)$4,039.330.76%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • paypal-usdPayPal USD(PYUSD)$1.000.03%
  • BittensorBittensor(TAO)$255.812.93%
  • shiba-inuShiba Inu(SHIB)$0.0000053.11%
  • quant-networkQuant(QNT)$200.11-1.37%
  • crypto-com-chainCronos(CRO)$0.0539402.76%
  • EthenaEthena(ENA)$0.2034460.75%
  • BitwayBitway(BTW)$1.7319.27%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • MemeCoreMemeCore(M)$1.107.87%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.01%
  • okbOKB(OKB)$110.312.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • pepePepe(PEPE)$0.00000515.53%
  • aaveAave(AAVE)$134.662.51%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Melanoma study finds mRNA vaccine combined with standard treatment could reduce recurrence

May 11, 2023
in Market & News
Reading Time: 1 min read
A A
ShareShareShareShareShare



In a stage two clinical trial, researchers found that adding an mRNA cancer vaccine to standard treatment reduced the chances for melanoma recurrence or death by 44 percent. NBC News’ Kristen Dahlgren spoke to one of the study’s doctors and a patient for more details.

» Subscribe to NBC News:
» Watch more NBC video:

YOU MAY ALSO LIKE

Major 7.7 magnitude earthquake shakes Panama

New video shows moments before ICE-involved shooting

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters

#NBCNews #Cancer #Vacciner

source

ShareTweetSendSharePin

Related Posts

Major 7.7 magnitude earthquake shakes Panama
Market & News

Major 7.7 magnitude earthquake shakes Panama

October 28, 2026
New video shows moments before ICE-involved shooting
Market & News

New video shows moments before ICE-involved shooting

October 28, 2026
Conditions intensify in Pensacola as Hurricane Isaias begins to move onshore
Market & News

Conditions intensify in Pensacola as Hurricane Isaias begins to move onshore

October 28, 2026
Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors
Market & News

Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors

October 28, 2026
Next Post
Interview: FASHION Photographer – What’s it really like?

Interview: FASHION Photographer - What's it really like?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Elon Musk invests B in David Ellison’s Skydance as media giant grapples with massive debt: report

Elon Musk invests $1B in David Ellison’s Skydance as media giant grapples with massive debt: report

October 22, 2026
Monthly Social Security checks to go up in 2027

Monthly Social Security checks to go up in 2027

October 25, 2026
16-year-old suspect in Bend, Oregon used long gun to shoot at school’s locked doors, police say

16-year-old suspect in Bend, Oregon used long gun to shoot at school’s locked doors, police say

October 24, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!